BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kazemian N, Mahmoudi M, Halperin F, Wu JC, Pakpour S. Gut microbiota and cardiovascular disease: opportunities and challenges. Microbiome 2020;8:36. [PMID: 32169105 DOI: 10.1186/s40168-020-00821-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 26.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang XN, Yu ZL, Chen JY, Li XY, Wang ZP, Wu M, Liu LT. The crosstalk between NLRP3 inflammasome and gut microbiome in atherosclerosis. Pharmacol Res 2022;:106289. [PMID: 35671922 DOI: 10.1016/j.phrs.2022.106289] [Reference Citation Analysis]
2 Tian L, Liu R, Zhou Z, Xu X, Feng S, Kushmaro A, Marks RS, Wang D, Sun Q. Probiotic Characteristics of Lactiplantibacillus Plantarum N-1 and Its Cholesterol-Lowering Effect in Hypercholesterolemic Rats. Probiotics Antimicrob Proteins 2022. [PMID: 35064922 DOI: 10.1007/s12602-021-09886-1] [Reference Citation Analysis]
3 Pontes KSDS, Guedes MR, Cunha MRD, Mattos SS, Barreto Silva MI, Neves MF, Marques BCAA, Klein MRST. Effects of probiotics on body adiposity and cardiovascular risk markers in individuals with overweight and obesity: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr 2021;40:4915-31. [PMID: 34358838 DOI: 10.1016/j.clnu.2021.06.023] [Reference Citation Analysis]
4 Lu D, Huang Y, Kong Y, Tao T, Zhu X. Gut microecology: Why our microbes could be key to our health. Biomed Pharmacother 2020;131:110784. [PMID: 33152942 DOI: 10.1016/j.biopha.2020.110784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Barcena ML, Aslam M, Pozdniakova S, Norman K, Ladilov Y. Cardiovascular Inflammaging: Mechanisms and Translational Aspects. Cells 2022;11:1010. [DOI: 10.3390/cells11061010] [Reference Citation Analysis]
6 Simó C, García-Cañas V. Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development. Food Funct 2020;11:6745-76. [PMID: 32686802 DOI: 10.1039/d0fo01237h] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
7 Yu H, Tang H, Deng C, Lin Q, Yu P, Chen S, Ruan J. RRM2 Improves Cardiomyocyte Proliferation after Myocardial Ischemia Reperfusion Injury through the Hippo-YAP Pathway. Dis Markers 2021;2021:5089872. [PMID: 34868394 DOI: 10.1155/2021/5089872] [Reference Citation Analysis]
8 Pagani IS, Poudel G, Wardill HR. A Gut Instinct on Leukaemia: A New Mechanistic Hypothesis for Microbiota-Immune Crosstalk in Disease Progression and Relapse. Microorganisms 2022;10:713. [DOI: 10.3390/microorganisms10040713] [Reference Citation Analysis]
9 Kirichenko TV, Markina YV, Sukhorukov VN, Khotina VA, Wu WK, Orekhov AN. A Novel Insight at Atherogenesis: The Role of Microbiome. Front Cell Dev Biol 2020;8:586189. [PMID: 33072766 DOI: 10.3389/fcell.2020.586189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Spisni E, Turroni S, Alvisi P, Spigarelli R, Azzinnari D, Ayala D, Imbesi V, Valerii MC. Nutraceuticals in the Modulation of the Intestinal Microbiota: Current Status and Future Directions. Front Pharmacol 2022;13:841782. [DOI: 10.3389/fphar.2022.841782] [Reference Citation Analysis]
11 Zhao X, Oduro PK, Tong W, Wang Y, Gao X, Wang Q. Therapeutic potential of natural products against atherosclerosis: Targeting on gut microbiota. Pharmacol Res 2021;163:105362. [PMID: 33285231 DOI: 10.1016/j.phrs.2020.105362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wong MK, Barbulescu P, Coburn B, Reguera-Nuñez E. Therapeutic interventions and mechanisms associated with gut microbiota-mediated modulation of immune checkpoint inhibitor responses. Microbes Infect 2021;23:104804. [PMID: 33652120 DOI: 10.1016/j.micinf.2021.104804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ciaravolo S, Martínez-López LM, Allcock RJN, Woodward AP, Mansfield C. Longitudinal Survey of Fecal Microbiota in Healthy Dogs Administered a Commercial Probiotic. Front Vet Sci 2021;8:664318. [PMID: 34235200 DOI: 10.3389/fvets.2021.664318] [Reference Citation Analysis]
14 Huang K, Liu C, Peng M, Su Q, Liu R, Guo Z, Chen S, Li Z, Chang G. Glycoursodeoxycholic Acid Ameliorates Atherosclerosis and Alters Gut Microbiota in Apolipoprotein E-Deficient Mice. J Am Heart Assoc 2021;10:e019820. [PMID: 33787322 DOI: 10.1161/JAHA.120.019820] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Ke S, Mitchell SJ, MacArthur MR, Kane AE, Sinclair DA, Venable EM, Chadaideh KS, Carmody RN, Grodstein F, Mitchell JR, Liu Y. Gut Microbiota Predicts Healthy Late-Life Aging in Male Mice. Nutrients 2021;13:3290. [PMID: 34579167 DOI: 10.3390/nu13093290] [Reference Citation Analysis]
16 Hajipour MJ, Aghaverdi H, Serpooshan V, Vali H, Sheibani S, Mahmoudi M. Sex as an important factor in nanomedicine. Nat Commun 2021;12:2984. [PMID: 34017011 DOI: 10.1038/s41467-021-23230-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
17 Nabrdalik K, Krzyżak K, Hajzler W, Drożdż K, Kwiendacz H, Gumprecht J, Lip GYH. Fat, Sugar or Gut Microbiota in Reducing Cardiometabolic Risk: Does Diet Type Really Matter? Nutrients 2021;13:639. [PMID: 33669342 DOI: 10.3390/nu13020639] [Reference Citation Analysis]
18 Paul E, Bu F, Fancourt D. Loneliness and Risk for Cardiovascular Disease: Mechanisms and Future Directions. Curr Cardiol Rep 2021;23:68. [PMID: 33961131 DOI: 10.1007/s11886-021-01495-2] [Reference Citation Analysis]
19 Liu L, Zhao Y, Ming J, Chen J, Zhao G, Chen ZY, Wang Y, Lei L. Polyphenol extract and essential oil of Amomum tsao-ko equally alleviate hypercholesterolemia and modulate gut microbiota. Food Funct 2021;12:12008-21. [PMID: 34755750 DOI: 10.1039/d1fo03082e] [Reference Citation Analysis]
20 Baghbani T, Nikzad H, Azadbakht J, Izadpanah F, Haddad Kashani H. Dual and mutual interaction between microbiota and viral infections: a possible treat for COVID-19. Microb Cell Fact. 2020;19:217. [PMID: 33243230 DOI: 10.1186/s12934-020-01483-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
21 Silva CBP, Elias-Oliveira J, McCarthy CG, Wenceslau CF, Carlos D, Tostes RC. Ethanol: striking the cardiovascular system by harming the gut microbiota. Am J Physiol Heart Circ Physiol 2021;321:H275-91. [PMID: 34142885 DOI: 10.1152/ajpheart.00225.2021] [Reference Citation Analysis]
22 Mba IE, Nweze EI. The use of nanoparticles as alternative therapeutic agents against Candida infections: an up-to-date overview and future perspectives. World J Microbiol Biotechnol 2020;36. [DOI: 10.1007/s11274-020-02940-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
23 Hoshi N, Inoue J, Sasaki D, Sasaki K. The Kobe University Human Intestinal Microbiota Model for gut intervention studies. Appl Microbiol Biotechnol 2021;105:2625-32. [PMID: 33718974 DOI: 10.1007/s00253-021-11217-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Gu I, Lam WS, Marasini D, Brownmiller C, Savary BJ, Lee JA, Carbonero F, Lee SO. In Vitro Fecal Fermentation Patterns of Arabinoxylan from Rice Bran on Fecal Microbiota from Normal-Weight and Overweight/Obese Subjects. Nutrients 2021;13:2052. [PMID: 34203983 DOI: 10.3390/nu13062052] [Reference Citation Analysis]
25 Ciernikova S, Mego M, Chovanec M. Exploring the Potential Role of the Gut Microbiome in Chemotherapy-Induced Neurocognitive Disorders and Cardiovascular Toxicity. Cancers (Basel) 2021;13:782. [PMID: 33668518 DOI: 10.3390/cancers13040782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Matsuoka T, Shimizu T, Minagawa T, Hiranuma W, Takeda M, Kakuta R, Kawamoto S. First case of an invasive Bacteroides dorei infection detected in a patient with a mycotic aortic aneurysm-raising a rebellion of major indigenous bacteria in humans: a case report and review. BMC Infect Dis 2021;21:625. [PMID: 34193073 DOI: 10.1186/s12879-021-06345-8] [Reference Citation Analysis]
27 Soto Chervin C, Gajewski T. Microbiome-based interventions: therapeutic strategies in cancer immunotherapy. Immuno-Oncology Technology 2020;8:12-20. [DOI: 10.1016/j.iotech.2020.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Cook MD, Hogue T. Exercise and the Microbiome: Mechanistic Perspectives of the Impact of Exercise on the Gut-Vascular Axis. mSystems 2021;6:e0065021. [PMID: 34402640 DOI: 10.1128/mSystems.00650-21] [Reference Citation Analysis]
29 Noguera-navarro C, Navas-carrillo D, Orenes-piñero E. Gut microbiota alterations and nutritional intervention in multiple sclerosis disease. Food Reviews International. [DOI: 10.1080/87559129.2022.2062771] [Reference Citation Analysis]
30 Vourakis M, Mayer G, Rousseau G. The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis. Int J Mol Sci 2021;22:8074. [PMID: 34360839 DOI: 10.3390/ijms22158074] [Reference Citation Analysis]
31 Camelo-Castillo A, Rivera-Caravaca JM, Orenes-Piñero E, Ramírez-Macías I, Roldán V, Lip GYH, Marín F. Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications. J Clin Med 2021;10:715. [PMID: 33670220 DOI: 10.3390/jcm10040715] [Reference Citation Analysis]
32 Zhu WJ, Liu Y, Cao YN, Peng LX, Yan ZY, Zhao G. Insights into Health-Promoting Effects of Plant MicroRNAs: A Review. J Agric Food Chem 2021;69:14372-86. [PMID: 34813309 DOI: 10.1021/acs.jafc.1c04737] [Reference Citation Analysis]
33 Kondubhatla K, Kaushal A, Daoud A, Shabbir H, Mostafa JA. Pro-Atherogenic Inflammatory Mediators in Inflammatory Bowel Disease Patients Increase the Risk of Thrombosis, Coronary Artery Disease, and Myocardial Infarction: A Scientific Dilemma. Cureus 2020;12:e10544. [PMID: 33062549 DOI: 10.7759/cureus.10544] [Reference Citation Analysis]
34 Arun KB, Madhavan A, Sindhu R, Emmanual S, Binod P, Pugazhendhi A, Sirohi R, Reshmy R, Awasthi MK, Gnansounou E, Pandey A. Probiotics and gut microbiome - Prospects and challenges in remediating heavy metal toxicity. J Hazard Mater 2021;420:126676. [PMID: 34329091 DOI: 10.1016/j.jhazmat.2021.126676] [Reference Citation Analysis]
35 Zeibich L, Koebele SV, Bernaud VE, Ilhan ZE, Dirks B, Northup-Smith SN, Neeley R, Maldonado J, Nirmalkar K, Files JA, Mayer AP, Bimonte-Nelson HA, Krajmalnik-Brown R. Surgical Menopause and Estrogen Therapy Modulate the Gut Microbiota, Obesity Markers, and Spatial Memory in Rats. Front Cell Infect Microbiol 2021;11:702628. [PMID: 34660336 DOI: 10.3389/fcimb.2021.702628] [Reference Citation Analysis]
36 Jie Z, Liang S, Ding Q, Li F, Sun X, Lin Y, Chen P, Cai K, Zhou H, Lu H, Wang X, Zhang T, Xiao L, Yang H, Wang J, Hou Y, Kristiansen K, Jia H, Xu X. Disease trends in a young Chinese cohort according to fecal metagenome and plasma metabolites. Medicine in Microecology 2021;9:100037. [DOI: 10.1016/j.medmic.2021.100037] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Sharma V, Sharma V, Shahjouei S, Li J, Chaudhary D, Khan A, Wolk DM, Zand R, Abedi V. At the Intersection of Gut Microbiome and Stroke: A Systematic Review of the Literature. Front Neurol 2021;12:729399. [PMID: 34630304 DOI: 10.3389/fneur.2021.729399] [Reference Citation Analysis]
38 Piccioni A, de Cunzo T, Valletta F, Covino M, Rinninella E, Raoul P, Zanza C, Mele MC, Franceschi F. Gut Microbiota and Environment in Coronary Artery Disease. Int J Environ Res Public Health 2021;18:4242. [PMID: 33923612 DOI: 10.3390/ijerph18084242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Panebianco C, Ciardiello D, Villani A, Maiorano BA, Latiano TP, Maiello E, Perri F, Pazienza V. Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspective. Semin Cancer Biol 2021:S1044-579X(21)00280-7. [PMID: 34838957 DOI: 10.1016/j.semcancer.2021.11.007] [Reference Citation Analysis]
40 Künstner A, Aherrahrou R, Hirose M, Bruse P, Ibrahim SM, Busch H, Erdmann J, Aherrahrou Z. Effect of Differences in the Microbiome of Cyp17a1-Deficient Mice on Atherosclerotic Background. Cells 2021;10:1292. [PMID: 34070975 DOI: 10.3390/cells10061292] [Reference Citation Analysis]
41 Kassan A, Ait-Aissa K, Kassan M. Hypothalamic miR-204 Induces Alteration of Heart Electrophysiology and Neurogenic Hypertension by Regulating the Sympathetic Nerve Activity: Potential Role of Microbiota. Cureus 2021;13:e18783. [PMID: 34692262 DOI: 10.7759/cureus.18783] [Reference Citation Analysis]
42 Zhang T, Zhu G, Lu B, Qian Z, Peng Q. Protein corona formed in the gastrointestinal tract and its impacts on oral delivery of nanoparticles. Med Res Rev 2021;41:1835-50. [DOI: 10.1002/med.21767] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
43 Shivani S, Chattopadhyay A, Chuang EY. Targeting the gut microbiome for non-communicable diseases: present and future. Ann Transl Med 2021;9:361. [PMID: 33842582 DOI: 10.21037/atm-21-144] [Reference Citation Analysis]
44 Bin-Jumah MN, Gilani SJ, Hosawi S, Al-Abbasi FA, Zeyadi M, Imam SS, Alshehri S, Ghoneim MM, Nadeem MS, Kazmi I. Pathobiological Relationship of Excessive Dietary Intake of Choline/L-Carnitine: A TMAO Precursor-Associated Aggravation in Heart Failure in Sarcopenic Patients. Nutrients 2021;13:3453. [PMID: 34684454 DOI: 10.3390/nu13103453] [Reference Citation Analysis]
45 Xu S, Zhang X, Liu S, Feng S, Xiang G, Xu C, Fan Z, Xu K, Wang N, Wang Y, Che J, Liu Z, Mu Y, Li K. Multi-Omic Analysis in a Metabolic Syndrome Porcine Model Implicates Arachidonic Acid Metabolism Disorder as a Risk Factor for Atherosclerosis. Front Nutr 2022;9:807118. [DOI: 10.3389/fnut.2022.807118] [Reference Citation Analysis]
46 Song W, Sun LY, Zhu ZJ, Wei L, Qu W, Zeng ZG, Yang YS. Characteristics of Gut Microbiota in Children With Biliary Atresia After Liver Transplantation. Front Physiol 2021;12:704313. [PMID: 34262484 DOI: 10.3389/fphys.2021.704313] [Reference Citation Analysis]
47 Beck LC, Granger CL, Masi AC, Stewart CJ. Use of omic technologies in early life gastrointestinal health and disease: from bench to bedside. Expert Rev Proteomics 2021;18:247-59. [PMID: 33896313 DOI: 10.1080/14789450.2021.1922278] [Reference Citation Analysis]
48 Melhem NJ, Taleb S. Tryptophan: From Diet to Cardiovascular Diseases. Int J Mol Sci 2021;22:9904. [PMID: 34576067 DOI: 10.3390/ijms22189904] [Reference Citation Analysis]
49 Yeh CF, Chen YH, Liu SF, Kao HL, Wu MS, Yang KC, Wu WK. Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis. Int J Mol Sci 2020;21:E8729. [PMID: 33227973 DOI: 10.3390/ijms21228729] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
50 Gawałko M, Agbaedeng TA, Saljic A, Müller DN, Wilck N, Schnabel R, Penders J, Rienstra M, van Gelder I, Jespersen T, Schotten U, Crijns HJGM, Kalman JM, Sanders P, Nattel S, Dobrev D, Linz D. Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications. Cardiovasc Res 2021:cvab292. [PMID: 34550344 DOI: 10.1093/cvr/cvab292] [Reference Citation Analysis]
51 Liang F, Lu X, Deng Z, Zhong H, Zhang W, Li Q, Zhou H, Liou Y, He X. Effect of Washed Microbiota Transplantation on Patients With Dyslipidemia in South China. Front Endocrinol 2022;13:827107. [DOI: 10.3389/fendo.2022.827107] [Reference Citation Analysis]
52 Coletto E, Latousakis D, Pontifex MG, Crost EH, Vaux L, Perez Santamarina E, Goldson A, Brion A, Hajihosseini MK, Vauzour D, Savva GM, Juge N. The role of the mucin-glycan foraging Ruminococcus gnavus in the communication between the gut and the brain. Gut Microbes 2022;14:2073784. [PMID: 35579971 DOI: 10.1080/19490976.2022.2073784] [Reference Citation Analysis]
53 Khan AA, Sirsat AT, Singh H, Cash P. Microbiota and cancer: current understanding and mechanistic implications. Clin Transl Oncol 2021. [PMID: 34387847 DOI: 10.1007/s12094-021-02690-x] [Reference Citation Analysis]
54 Huang K, Wang Y, Bai Y, Luo Q, Lin X, Yang Q, Wang S, Xin H. Gut Microbiota and Metabolites in Atrial Fibrillation Patients and Their Changes after Catheter Ablation. Microbiol Spectr 2022;:e0107721. [PMID: 35384710 DOI: 10.1128/spectrum.01077-21] [Reference Citation Analysis]
55 Hu S, Luo L, Bian X, Liu RH, Zhao S, Chen Y, Sun K, Jiang J, Liu Z, Zeng L. Pu-erh Tea Restored Circadian Rhythm Disruption by Regulating Tryptophan Metabolism. J Agric Food Chem 2022. [PMID: 35475616 DOI: 10.1021/acs.jafc.2c01883] [Reference Citation Analysis]
56 Alhajri N, Khursheed R, Ali MT, Abu Izneid T, Al-Kabbani O, Al-Haidar MB, Al-Hemeiri F, Alhashmi M, Pottoo FH. Cardiovascular Health and The Intestinal Microbial Ecosystem: The Impact of Cardiovascular Therapies on The Gut Microbiota. Microorganisms 2021;9:2013. [PMID: 34683334 DOI: 10.3390/microorganisms9102013] [Reference Citation Analysis]
57 Shen L, Shen K, Bai J, Wang J, Singla RK, Shen B. Data-driven microbiota biomarker discovery for personalized drug therapy of cardiovascular disease. Pharmacol Res 2020;161:105225. [PMID: 33007417 DOI: 10.1016/j.phrs.2020.105225] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Jung E, Romero R, Yeo L, Gomez-Lopez N, Chaemsaithong P, Jaovisidha A, Gotsch F, Erez O. The etiology of preeclampsia. Am J Obstet Gynecol 2022;226:S844-66. [PMID: 35177222 DOI: 10.1016/j.ajog.2021.11.1356] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
59 Kwek E, Zhu H, Ding H, He Z, Hao W, Liu J, Ma KY, Chen ZY. Peony seed oil decreases plasma cholesterol and favorably modulates gut microbiota in hypercholesterolemic hamsters. Eur J Nutr 2022. [PMID: 35107625 DOI: 10.1007/s00394-021-02785-9] [Reference Citation Analysis]
60 Hajipour MJ, Saei AA, Walker ED, Conley B, Omidi Y, Lee KB, Mahmoudi M. Nanotechnology for Targeted Detection and Removal of Bacteria: Opportunities and Challenges. Adv Sci (Weinh) 2021;8:e2100556. [PMID: 34558234 DOI: 10.1002/advs.202100556] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
61 Manosso LM, Arent CO, Borba LA, Ceretta LB, Quevedo J, Réus GZ. Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection. Cells 2021;10:1993. [PMID: 34440767 DOI: 10.3390/cells10081993] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Yang C, Starnecker F, Pang S, Chen Z, Güldener U, Li L, Heinig M, Schunkert H. Polygenic risk for coronary artery disease in the Scottish and English population. BMC Cardiovasc Disord 2021;21:586. [PMID: 34876023 DOI: 10.1186/s12872-021-02398-4] [Reference Citation Analysis]
63 Hu X, Fan Y, Li H, Zhou R, Zhao X, Sun Y, Zhang S. Impacts of Cigarette Smoking Status on Metabolomic and Gut Microbiota Profile in Male Patients With Coronary Artery Disease: A Multi-Omics Study. Front Cardiovasc Med 2021;8:766739. [PMID: 34778417 DOI: 10.3389/fcvm.2021.766739] [Reference Citation Analysis]
64 Tuganbaev T, Honda K. Non-zero-sum microbiome immune system interactions. Eur J Immunol 2021;51:2120-36. [PMID: 34242413 DOI: 10.1002/eji.202049065] [Reference Citation Analysis]
65 Wallace RK. The Microbiome in Health and Disease from the Perspective of Modern Medicine and Ayurveda. Medicina (Kaunas) 2020;56:E462. [PMID: 32932766 DOI: 10.3390/medicina56090462] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
66 Deng P, Valentino T, Flythe MD, Moseley HNB, Leachman JR, Morris AJ, Hennig B. Untargeted Stable Isotope Probing of the Gut Microbiota Metabolome Using 13C-Labeled Dietary Fibers. J Proteome Res 2021;20:2904-13. [PMID: 33830777 DOI: 10.1021/acs.jproteome.1c00124] [Reference Citation Analysis]
67 Meng L, Song Z, Liu A, Dahmen U, Yang X, Fang H. Effects of Lipopolysaccharide-Binding Protein (LBP) Single Nucleotide Polymorphism (SNP) in Infections, Inflammatory Diseases, Metabolic Disorders and Cancers. Front Immunol 2021;12:681810. [PMID: 34295331 DOI: 10.3389/fimmu.2021.681810] [Reference Citation Analysis]
68 Perrelli A, Retta SF. Polymorphisms in genes related to oxidative stress and inflammation: Emerging links with the pathogenesis and severity of Cerebral Cavernous Malformation disease. Free Radic Biol Med 2021;172:403-17. [PMID: 34175437 DOI: 10.1016/j.freeradbiomed.2021.06.021] [Reference Citation Analysis]
69 Cheng CK, Huang Y. The gut-cardiovascular connection: new era for cardiovascular therapy. Medical Review 2021;1:23-46. [DOI: 10.1515/mr-2021-0002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
70 Abadi B, Yazdanpanah N, Nokhodchi A, Rezaei N. Smart biomaterials to enhance the efficiency of immunotherapy in glioblastoma: State of the art and future perspectives. Adv Drug Deliv Rev 2021;179:114035. [PMID: 34740765 DOI: 10.1016/j.addr.2021.114035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
71 Padilla P, Andrade MJ, Peña FJ, Rodríguez A, Estévez M. Molecular mechanisms of the disturbance caused by malondialdehyde on probiotic Lactobacillus reuteri PL503. Microb Biotechnol 2020. [PMID: 33356002 DOI: 10.1111/1751-7915.13723] [Reference Citation Analysis]
72 He K, Yan W, Sun C, Liu J, Bai R, Wang T, Qian W. Alterations in the diversity and composition of gut microbiota in weaned piglets infected with Balantioides coli. Vet Parasitol 2020;288:109298. [PMID: 33171414 DOI: 10.1016/j.vetpar.2020.109298] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
73 Wu P, Zhu T, Tan Z, Chen S, Fang Z. Role of Gut Microbiota in Pulmonary Arterial Hypertension. Front Cell Infect Microbiol 2022;12:812303. [DOI: 10.3389/fcimb.2022.812303] [Reference Citation Analysis]
74 Zheng S, Piao C, Liu Y, Liu X, Liu T, Zhang X, Ren J, Liu Y, Zhu B, Du J. Glycan Biosynthesis Ability of Gut Microbiota Increased in Primary Hypertension Patients Taking Antihypertension Medications and Potentially Promoted by Macrophage-Adenosine Monophosphate-Activated Protein Kinase. Front Microbiol 2021;12:719599. [PMID: 34803940 DOI: 10.3389/fmicb.2021.719599] [Reference Citation Analysis]